Downloads
-
Reducing Product Loss In The Biomanufacturing Cold Chain
3/25/2024
Traditional single-use bags are vulnerable to damage at multiple points in the cold chain. Learn about flexible containers that minimize the risk and bring strength and durability to your cold chain.
-
AAV Process Intensification Using High Salt Lysis And Salt Tolerant Endonuclease
3/25/2024
In the production of adeno-associated virus (AAV) vectors, cell lysis involves challenges addressed through high salt concentrations and a salt-tolerant endonuclease, enhancing titer and infectivity.
-
Novel Enzyme For Nucleic Acid Removal At High Salt Concentrations
3/25/2024
Learn about a best-in-class solution designed for efficient nucleic acid removal at high salt concentrations.
-
Endonucleases With High Purity And Activity For Any Application
3/25/2024
Explore a portfolio of endonucleases with exceptionally high purity and activity for your application.
-
Quick Takes From Takeda Austria’s Annex 1 Rollout
3/25/2024
At ISPE's 2024 Aseptic Conference, Takeda Austria's site head spoke about lessons learned from Annex 1 implementation. We caught up with her and asked for the highlights.
-
Find The Right T Cell Expansion And Phenotype Balance For Cell Therapy
3/22/2024
Explore this study that works to determine the optimal concentrations of IL-7 and IL-15 for T cell expansion, as well as how to produce the desired phenotype while requiring less protein.
-
Touch-Free T Cell Expansion With A Fill-And-Forget Workflow
3/22/2024
Explore a bioreactor for large-scale, low-cost immune cell therapy manufacturing paired with a "fill-and-forget" workflow and discover how robust T cell expansion can be achieved.
-
Navigating Grades And Sources Of Materials In Drug Manufacturing
3/22/2024
From raw materials to finished dosage forms, understanding material quality is essential in drug manufacturing. This article examines how material grades and sources guide selection for optimal safety and functionality.
-
Fine-tuning Analytical Development Strategies For Every Phase
3/22/2024
Analytical challenges morph phase-by-phase during drug development. Three Novartis scientists describe a platform approach based on guidance from the ICH and USP.
-
Testing At WuXi Advanced Therapies
3/21/2024
Learn how a partner offering a comprehensive suite of integrated testing services designed to navigate the complexities of cell and gene therapies is critical for accelerating development timelines.